HCPCS Level II code C9782 designates a complex, blinded investigational procedure for select patients with symptomatic heart failure or refractory angina. The code encompasses transcatheter intramyocardial transplantation of autologous bone marrow cells (or placebo), autologous bone marrow harvest and preparation, left heart catheterization with ventriculography, and all associated laboratory and imaging services. This code is relevant nationally as it captures bundled investigational cardiac interventions performed under an approved Investigational Device Exemption (IDE) study and affects claims processing, coverage determinations, and study reimbursement reporting.

Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise summary of the clinical context of the procedure, the service setting, and what the code represents for billing and study documentation. The publication provides benchmarks and policy-relevant context for coverage and reimbursement considerations, flags common modifiers reported with this code, and explains the procedural components bundled under C9782. The content is intended for national audiences including billing professionals, clinical research administrators, and health policy analysts.

Data not available in the input: specific associated taxonomies, ICD-10 diagnoses, related codes, payer-specific coverage rules, and service line details.